[SuperAlerts] $GILD Announces top-line results from two Phase 3 studies evaluating Momelotinib for patients with Myelofibrosis; SIMPLIFY-2 did not achieve its primary endpoint - Source TradeTheNews.com


[SuperAlerts] $GILD slo sto 20 ...earnings Nov 1 bought some calls for next week for earnings run slo sto play...bio in general..good valuation


[TimAlerts] i assume since $SRPT and $GILD are both on the scanner with the tag stock rumours that the rumour is about the 2. I don't know what the rumour is because only my desktop scanner is running. Just passing on the alert you would have to do the DD to find out why it moved $0.80 cent on that sorry

of 23